Elspar

Active Ingredient(s): L-Asparaginase
FDA Approved: * February 1, 1994
Pharm Company: * MERCK
Category: Cancer

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".



Elspar Overview

Asparaginase is an enzyme that is used as a medication and in food manufacturing.[1][2] As a medication, L-asparaginase is used to treat acute lymphoblastic leukemia (ALL).[1] It is given by injection into a vein, muscle, or under the skin.[1] A pegylated version is also available.[3] In food manufacturing it is used to decrease acrylamide.[2] Common side effects when used by injection include alle...

Read more Elspar Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Asparaginase

Recent Elspar Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

L-Asparaginase
  • Injection: 10000unit
  • Vial: 10,000iu/vial
Note: Above list includes dosages for all drugs with the same combination of active ingredients.

Other drugs which contain L-Asparaginase or a similar ingredient: (1 result)